Surface-Engineered Design of Efficient Luminescent Europium(III) Complex-Based Hydroxyapatite Nanocrystals for Rapid HeLa Cancer Cell Imaging
Source abstract
Abstract
We synthesized hydroxyapatite nanocrystals under the existence of tris(2,2,6,6-tetramethyl-3,5-heptanedionato)europium(III) (EuTH) complex to form inorganic/organic hybrid nanocrystal (EHA). Then, the folic acid derivative (folate N-hydroxysuccinimidyl ester (FA-NHS)) as the targeting ligand for the HeLa cancer cells was immobilized on the EHA by the mediation of both 3-aminopropyltriethoxysilane and methyltriethoxysilane molecules. Here, we investigated the photofunctions based on the interfacial interactions between the FA-NHS and EHA nanohybrids for preparing the novel bioimaging nanomaterials. As a result, the photofunctions could be changed by the FA-NHS molecular occupancy on the EHA. When the molecular occupancy ratio to the EHA surfaces is at around 3–5%, the intense luminescence from the f–f transition of the Eu3+ ions as well as the charge transfer between the EuTH–FA-NHS was observed to exhibit higher quantum efficiency. Moreover, effective dispersibility in phosphate-buffered saline was confirmed with immobilizing the positively charged FA-NHS. The cytotoxicity against the HeLa cells was also evaluated to verify whether the nanohybrids can be the candidate for cell imaging. The affinity and noncytotoxicity between the FA-NHS-immobilized EHA nanohybrids and cells were monitored for 3 days. Red luminescence from the cells could be observed, and the labels with following the cellular shapes were achieved by an additional culture time of 1 h after injecting the FA-NHS-immobilized EHA nanohybrids to the spheres, indicating the rapid bioimaging process. Therefore, this is the first successful report to describe the synthesis of inorganic–organic nanohybrid systems for controlling the EuTH–FA-NHS interactions. The photofunction of the interfacial interactions was successfully designed to provide “efficient luminescent ability” as well as “rapid targeting to the cancer cells” in one particle.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Luminescence Properties of Advanced Materials · Bone Tissue Engineering Materials · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Materials Science and Technology, Nagaoka University of Technology, Kamitomioka 1603-1, Nagaoka, Niigata 940-2188, Japan
Graduate School of Dental Medicine, Hokkaido University, Sapporo 060-8586, Japan
Funding
Japan Society for the Promotion of Science
References (63)
Show source-provided references
1. 10.1016/j.addr.2012.09.03310.1016/j.addr.2012.09.033 ↗
2. 10.1016/j.jlumin.2018.03.03210.1016/j.jlumin.2018.03.032 ↗
3. 10.1021/acssuschemeng.7b0379710.1021/acssuschemeng.7b03797 ↗
4. 10.1186/s11671-016-1651-y10.1186/s11671-016-1651-y ↗
5. 10.1039/C6NR03369E10.1039/C6NR03369E ↗
6. 10.1016/j.molstruc.2018.03.02110.1016/j.molstruc.2018.03.021 ↗
7. 10.1016/j.jallcom.2015.08.21910.1016/j.jallcom.2015.08.219 ↗
8. 10.1016/j.jallcom.2015.08.27610.1016/j.jallcom.2015.08.276 ↗
9. 10.1039/C7RA12536D10.1039/C7RA12536D ↗
10. 10.1021/cm950491010.1021/cm9504910 ↗
11. 10.1039/C6DT03833F10.1039/C6DT03833F ↗
12. 10.1039/c3dt51117k10.1039/c3dt51117k ↗
13. 10.1016/j.optmat.2018.01.03210.1016/j.optmat.2018.01.032 ↗
14. 10.1002/ejic.20180073210.1002/ejic.201800732 ↗
15. 10.1039/C7CC06753D10.1039/C7CC06753D ↗
16. 10.1016/j.msec.2016.10.08210.1016/j.msec.2016.10.082 ↗
17. 10.1007/s10856-008-3499-x10.1007/s10856-008-3499-x ↗
18. 10.1016/j.actbio.2012.07.02410.1016/j.actbio.2012.07.024 ↗
19. 10.1021/acs.cgd.5b0159910.1021/acs.cgd.5b01599 ↗
20. 10.1016/j.msec.2017.08.03210.1016/j.msec.2017.08.032 ↗
21. 10.1007/s10971-016-4194-x10.1007/s10971-016-4194-x ↗
22. 10.1016/j.ceramint.2013.10.07010.1016/j.ceramint.2013.10.070 ↗
23. 10.1016/j.colcom.2016.04.00310.1016/j.colcom.2016.04.003 ↗
24. 10.1016/S0022-3697(98)00056-010.1016/S0022-3697(98)00056-0 ↗
25. 10.1021/acsbiomaterials.6b0016910.1021/acsbiomaterials.6b00169 ↗
26. 10.1016/j.msec.2015.08.02010.1016/j.msec.2015.08.020 ↗
27. 10.1016/j.optmat.2017.02.03610.1016/j.optmat.2017.02.036 ↗
28. 10.1016/j.powtec.2012.11.00310.1016/j.powtec.2012.11.003 ↗
29. 10.1007/s00604-016-1970-910.1007/s00604-016-1970-9 ↗
30. 10.1016/j.msec.2015.09.01410.1016/j.msec.2015.09.014 ↗
31. 10.1016/j.pnsc.2013.01.01610.1016/j.pnsc.2013.01.016 ↗
32. 10.1021/acsami.7b1928110.1021/acsami.7b19281 ↗
33. Turek J. J. · J. Cell Sci. · 1993 · 106 · 42310.1242/jcs.106.1.423 ↗
34. Poe M. · J. Biol. Chem. · 1977 · 252 · 372410.1016/S0021-9258(17)40312-7 ↗
35. 10.1016/j.chemphys.2009.10.02610.1016/j.chemphys.2009.10.026 ↗
36. 10.1038/793310.1038/7933 ↗
37. 10.1021/ja057769210.1021/ja0577692 ↗
38. 10.1021/ja01269a02310.1021/ja01269a023 ↗
39. 10.1088/0953-8984/22/45/45411610.1088/0953-8984/22/45/454116 ↗
40. 10.1016/j.jcis.2013.02.03010.1016/j.jcis.2013.02.030 ↗
41. 10.1017/CBO9781107415324.00410.1017/CBO9781107415324.004 ↗
42. 10.1080/1478644920862036410.1080/14786449208620364 ↗
43. 10.1021/ac200195n10.1021/ac200195n ↗
44. 10.1021/nn302032210.1021/nn3020322 ↗
45. Fields R. · 1972 · 25 · 464
46. 10.1021/ar800174z10.1021/ar800174z ↗
47. 10.1167/iovs.04-126310.1167/iovs.04-1263 ↗
48. 10.1351/pac19855704060310.1351/pac198557040603 ↗
49. 10.1016/j.optmat.2018.07.01410.1016/j.optmat.2018.07.014 ↗
50. 10.1016/j.jlumin.2007.09.01210.1016/j.jlumin.2007.09.012 ↗
51. 10.1021/ac60190a02610.1021/ac60190a026 ↗
52. 10.1002/app.3917510.1002/app.39175 ↗
53. 10.1002/adma.20130425310.1002/adma.201304253 ↗
54. 10.1063/1.171198310.1063/1.1711983 ↗
55. 10.1021/bm900853z10.1021/bm900853z ↗
56. 10.1021/ac401377n10.1021/ac401377n ↗
57. 10.1021/acs.bioconjchem.6b0071510.1021/acs.bioconjchem.6b00715 ↗
58. 10.1002/smll.20090140310.1002/smll.200901403 ↗
59. 10.1016/0006-2952(62)90015-110.1016/0006-2952(62)90015-1 ↗
60. 10.1016/j.jpcs.2018.06.03110.1016/j.jpcs.2018.06.031 ↗
61. 10.1016/j.ijpharm.2018.07.03610.1016/j.ijpharm.2018.07.036 ↗
62. 10.1016/j.msec.2018.06.05410.1016/j.msec.2018.06.054 ↗
63. 10.1016/j.msec.2018.05.07910.1016/j.msec.2018.05.079 ↗